WO2005074845A1 - Enhancing tissue ingrowth for contraception - Google Patents

Enhancing tissue ingrowth for contraception Download PDF

Info

Publication number
WO2005074845A1
WO2005074845A1 PCT/US2005/003310 US2005003310W WO2005074845A1 WO 2005074845 A1 WO2005074845 A1 WO 2005074845A1 US 2005003310 W US2005003310 W US 2005003310W WO 2005074845 A1 WO2005074845 A1 WO 2005074845A1
Authority
WO
WIPO (PCT)
Prior art keywords
occluding
metallic
component
elements
metallic material
Prior art date
Application number
PCT/US2005/003310
Other languages
French (fr)
Inventor
Jeffrey P. Callister
William S. Tremulis
Original Assignee
Ams Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ams Research Corporation filed Critical Ams Research Corporation
Priority to CN2005800097909A priority Critical patent/CN1937976B/en
Priority to EP05722687A priority patent/EP1715826B1/en
Priority to CA2555011A priority patent/CA2555011C/en
Priority to AU2005209871A priority patent/AU2005209871B2/en
Publication of WO2005074845A1 publication Critical patent/WO2005074845A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12104Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in an air passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12177Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/20Vas deferens occluders; Fallopian occluders
    • A61F6/22Vas deferens occluders; Fallopian occluders implantable in tubes
    • A61F6/225Vas deferens occluders; Fallopian occluders implantable in tubes transcervical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12063Details concerning the detachment of the occluding device from the introduction device electrolytically detachable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B2017/320004Surgical cutting instruments abrasive
    • A61B2017/320008Scrapers

Definitions

  • This invention generally relates to the field of occluding devices, delivery systems for such devices and the method of using such devices and systems in the occlusion of body passageways.
  • the invention is particularly useful for the occluding reproductive lumens such as a female patient's fallopian tubes or a male patient's vas deferens to affect contraception.
  • stent-like devices within reproductive lumens for obstructing such lumens as a contraceptive alternative to tubal ligation.
  • placing a stent alone or a stent with fibrous material or similar occluding device may not create sufficient or permanent obstruction of the reproductive lumen depending on the nature of the obstructive device.
  • the obstructive device may be too small to provide complete obstruction of the reproductive lumen, or the device may be permeable to cell movement.
  • An occluding device placed in a reproductive lumen may not securely seal against the luminal walls, or may initially allow egg cells or sperm cells to pass through the device until tissue growth completes the occlusion of the reproductive lumen and thus allow pregnancy to occur. Additionally, the occluding device might create an obstruction sufficient to prevent the passage of an egg but allow sperm cells to pass through or by the occluding device, fertilizing an egg upstream of the obstruction and resulting in an ectopic pregnancy. [0004] The use of an occluding contraceptive or sterilization device, particularly with mesh or fibrous material to promote tissue ingrowth, has been proposed (See for example U.S. Patent No. 6,432,116).
  • tissue growth includes but is not limited to cell multiplication and/or growth resulting in tissue formation into, onto, or surrounding an occluding device.
  • the tissue growth may be epithelialization, scar formation, or other cell growth or multiplication.
  • An occluding device having features of the invention generally includes an occluding component which is configured to expand within the body lumen to be occluded and first and second metallic elements which are associated with the occluding component and which are configured to generate electrical activity within a patient's body lumen to enhance the growth of tissue into or onto the occluding component of the occluding device.
  • the occluding device has a occluding component and has two metallic components formed of different metallic material and electrically connected to effect galvanic activity when the occluding device contacts body fluid or other conductive fluid to stimulate cellular growth into or on the occluding component of the device.
  • One or both of the metallic elements may be part of the occluding device or separate elements directly or indirectly attached to the occluding device.
  • the occluding device has a occluding component and has two separate metallic components which are configured to be electrically connected to an electrical power source (e.g. a battery or other low voltage source) to generate the electrical activity sufficient to stimulate cell growth onto or within the occluding component of the device.
  • an electrical power source e.g. a battery or other low voltage source
  • body fluid or other electrically conductive fluid e.g. saline
  • One particularly useful application for occluding devices embodying features of the invention is directed to occluding a reproductive lumen such as a fallopian tube or a vans deferens for contraceptive purposes.
  • a reproductive lumen such as a fallopian tube or a vans deferens for contraceptive purposes.
  • one of the metallic elements or one group of the metallic elements configured for developing electrical activity in the body lumen may be formed of copper to provide further contraceptive action in addition to the occlusion of the lumen.
  • therapeutic or diagnostic agents by be employed with the occluding device for contraceptive or other uses, e.g. antibiotics, chemotherapy.
  • the occluding component can be coated with a polymer having impregnated therein an agent such as a drug, enzyme or protein, for inducing or promoting tissue growth.
  • the surface of the occluding component may be plated with or otherwise incorporated with an elutable inflammatory material to produce an inflammatory response in the tissue of the wall defining the body lumen, which further contributes to the obstruction of the lumen.
  • Inflammatory materials include copper or copper alloys.
  • Other inflammatory materials such as radioactive materials (emitting alpha, beta or gamma particles) may be used alone or in conjunction with other inflammatory materials.
  • the occluding device embodying features of the invention preferably has an occluding component that at least in part has a first delivery configuration with small transverse dimensions suitable for delivery to the chosen location in a reproductive or other body lumen and a second expanded configuration larger in transverse dimensions than the first configuration to facilitate securing the occluding component of the device within the reproductive or body lumen.
  • the occluding component of the device may be balloon expandable or self-expandable from the first configuration to the second configuration to occlude the body lumen.
  • the occluding device may be a tubular stent-like structure, such as described in U.S. Patent Applications Serial Nos.
  • the occluding device may have one or more spider-like constructions shown in co-pending application Serial No. 10/746,131 , filed on December 24, 2003.
  • the occluding component will generally be about 1 to about 5 mm, preferably about 2 to about 4 mm in transverse dimension in the expanded configuration and will generally be about 0.5 to about 8 cm, preferably about 1.5 to about 4 cm in length.
  • the occluding device having features of the invention is placed in a contracted configuration to facilitate introduction and advancement of the device within the reproductive lumen or other body lumen, usually within an inner lumen of a delivery sheath. Once in the desired position within a patient's body lumen, the delivery sheath is withdrawn while the occluding device is held in-place at the desired location.
  • the sheath withdrawal exposes the occluding device at the chosen site and the occluding device is expanded either by inflating a balloon within the inner lumen of the occluding component or from self expansion due to the nature and condition of the metallic material of which the occluding component is made.
  • An exposed portion of the occluding device may expand or be expanded before the entire occluding device is discharged from the delivery sheath.
  • Self-expanding occluding components of the device may be formed of superelastic NITINOL with an austenite phase that is stable at body temperature, i.e.
  • the material of the occluding component will not transform from the austenite phase to a martensite phase at body temperature except by the application of stress.
  • the occluding component may also be formed of a heat expandable metallic material such as shape memory NITINOL which has a stable martensite phase at body temperature and which returns to a remembered expanded condition when heated above the martensite-to-austenite transition temperature causing the occluding component to expand within the patient's body lumen.
  • the metallic elements associated with the occluding component and which generate the electrical activity within the body lumen to stimulate tissue growth may be formed at least in part of suitable conductive metallic materials such as stainless steel, NiTi alloy, platinum, tantalum, copper and gold. Other conductive materials are suitable.
  • the metallic elements may be part of the occluding component or be separate elements which are directly or indirectly secured to the occluding component. They may be electrically connected through one or more electrical conductors or even the occluding component itself.
  • Fibrous strands or bundles thereof, fibrous mesh, porous polymer bodies and the like may be disposed within or on the occluding device to facilitate tissue ingrowth in addition to the electrical stimulation of tissue growth.
  • the fibrous bundle, fibrous mesh or porous polymeric bodies may be disposed in either balloon expandable or self-expanding occluding devices.
  • mesh, fibrous or porous polymeric material within the inner lumen of balloon expandable occluding components can make balloon placement within the inner lumen difficult.
  • an electrolyte such as body fluids or saline or both to stimulate tissue growth.
  • Figure 1 is an elevational view of an occluding device embodying features of the invention with an occluding component in a first, contracted configuration.
  • Figure 2 is a transverse cross sectional view of the device shown in
  • Figure 3 is an elevational view of the device shown in Figure 1 , in a second, expanded configuration.
  • Figure 5 is an elevational view of an alternative occluding device embodying features of the invention having bundles of fibrous strands intermittently spaced in a plurality of sections within the inner lumen of the occluding component.
  • Figure 6 is an elevational view of another alternative occluding device embodying features of the invention having a fibrous mesh of woven strands disposed at one end of the occluding component.
  • Figure 7 is a partial end view of the fibrous mesh shown in Figure 6.
  • Figure 8 is a longitudinal cross sectional view of the occluding device shown in Figure 6, disposed within a body lumen and illustrating tissue growth into and on the occluding component.
  • Figure 9 is a transverse cross sectional view of the device shown in
  • Figure 10 illustrates another alternative occluding device embodying features of the invention which is disposed in an unexpanded configuration within a body lumen and which has a fibrous jacket or sock on an outer surface of the occluding component.
  • Figure 11 illustrates the device shown in FIG. 10 in an expanded configuration.
  • Figure 12 is an elevational view of an occluding device embodying features of the invention with a metallic rod within the interior of the occluding component in an unexpanded configuration.
  • Figure 13 is an elevational view of an occlusive device of Figure 12 in its expanded configuration.
  • Figure 14 is a transverse cross-sectional view of a modification of the occluding device with the inner rod or wire deployed within a fibrous body in the interior of the occluding component.
  • Figure 15 illustrates an occluding device embodying features of the invention having a helically shaped occluding component and a helically shaped member of different metallic composition which interfits within the spacing between the turns of the helically shaped occluding component.
  • Figure 16 illustrates an occluding device embodying features of the invention comprising an occluding component as shown in Figure 15 with a tightly coiled helical member within the inner lumen of the occluding component.
  • Figure 17 is an isometric view of an alternative occluding device comprising two sheets of metal sheet or foil formed of different metals;
  • Figure 18 is an isometric view of an alternative occluding device having granules of different metals on its surface;
  • Figure 19 is a schematic view of a female reproductive anatomy with the occluding device embodying features of the invention configured for deployment within a female patient's fallopian tube.
  • Figure 20 is an elevational view partially is section of the occluding device shown in Figure 19 disposed within the fallopian tube of a female patient and which has an external electrical source.
  • Figure 21 is a perspective view of an alternative occluding device having an occluding component with several spider-like members disposed along the supporting shaft.
  • DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION [0038]
  • Figures 1-4 schematically illustrate an occluding contraceptive device
  • FIG. 10 embodying features of the invention that generally includes an expandable stent- like occluding component or structure 11 having a first open end 12, a second open end 13, a lumen 14 extending therein and a fibrous member 15 within the inner lumen extending along a substantial length thereof.
  • Figures 1 and 2 depict the device 10 in a delivery configuration for introduction into and advancement within the patient's reproductive lumen.
  • Figures 3 and 4 depict the device in an expanded configuration.
  • a fibrous member 15 is transversely disposed in the occluding structure 11.
  • woven or interspersed wire element 16 is formed of one metallic material and woven or interspersed wire element 17 is formed of a second different metallic material.
  • the metallic wires generate sufficient galvanic activity with respect to the first metallic material to stimulate tissue growth when disposed within a patient's body lumen and in contact with a body or other conductive fluid.
  • wire 16 may be made of stainless steel and wire 17 may be made of copper.
  • the fibrous member 15 may have a plurality of biocompatible, non-metallic strands (e.g. PET, nylon, Hytrel) to facilitate cellular growth to augment that provided by the galvanic activity. [0040] As illustrated in Figure 4, the fibrous member 15 may be configured to expand when the occluding device 10 is expanded to the expanded configuration, so that the fibrous member 15 extends across the expanded lumen 14.
  • the stent-like occluding component 11 has an open, lattice-type structure facilitating tissue ingrowth through the wall thereof in the expanded configuration that facilitates securing the occluding component to the wall defining the reproductive lumen as well as occluding the reproductive lumen.
  • the occluding component 11 is of a diameter which is about equal to or slightly larger than the dimensions of the reproductive lumen within which the contraceptive device 10 is to be disposed.
  • the expanded transverse dimensions may be about 0.05 mm to about 5 mm, preferably about 0.1 to about 3 mm.
  • the fibrous member 15 is permeable to facilitate epithelialization or other tissue ingrowth, and the complex comprising the fibrous member with the tissue ingrowth occludes the reproductive lumen sufficiently to prevent the passage of reproductive cells therethrough.
  • the metallic strands forming in part the fibrous member are permeable to facilitate epithelialization or other tissue ingrowth, and the complex comprising the fibrous member with the tissue ingrowth occludes the reproductive lumen sufficiently to prevent the passage of reproductive cells therethrough.
  • an occluding device may be formed of the same metallic material and in contact with the occluding component 11 which is formed of a different metallic material to generate sufficient galvanic activity to stimulate tissue growth.
  • occluding component 21 similar to that shown in Figure 1
  • fibrous members 22, 23 and 24 disposed within the inner lumen 25 of occluding component 21.
  • the individual fibrous members 22-24 are spaced along the length of the tubular occluding component 21 with fibrous member 22 and 23 being within the ends of the occluding component and fibrous member 24 being centrally spaced.
  • Three fibrous members 22-24 are illustrated but a greater or lesser number of fibrous members may be disposed within the inner lumen 25.
  • the individual filaments or strands of a single fibrous member may be formed of different metallic material
  • the metallic filaments of one fibrous member may be different metallic material from the metallic filaments of an adjacent fibrous member or the metallic filaments of one or more of the fibrous members may be formed of metallic material different from the metallic material of the occluding component 21 in order to develop sufficient galvanic activity to stimulate tissue growth into or onto the device 10.
  • the occluding component 21 may have one tubular section
  • the filaments of the mesh members may be formed of metallic material different from the metallic material of one or both of the tubular sections 23 and 24 to vary the galvanic activity along the length of the occluding component when disposed in body fluids or other electrically conductive fluids. While not shown, the tubular segments 26 and 27 may be separated and insulated by fibrous members disposed therebetween.
  • FIGS 6 and 7 illustrate an occluding device 30 having an occluding component 31 with a permeable mesh member 32 formed of a plurality of woven strands 33 and 34 which extend across open end 35 of the occluding component 31 and facilitate tissue growth and occlude a body lumen into which the occluding device is deployed.
  • Some or all of the woven strands 33 may be formed of a first metallic material and some or all of woven strands 34 may be formed of a metallic material different from that of strands 33.
  • the metallic strands 33 or 34 of mesh member 32 may be formed of a metallic material different from the metallic material of the occluding component 31 .
  • Figure 7 is an end view of the device illustrated in Figure 6, illustrating the woven strands 33 and 34 forming the mesh member 32.
  • the mesh member 32 may comprise a variety of suitable permeable structures which support tissue growth.
  • the mesh member 32 may be replaced with a foamed porous membrane formed of biocompatible materials. The electrical activity stimulates and enhances tissue growth as described above.
  • FIGs 8 and 9 schematically illustrate the occluding device 30 shown in Figures 6 and 7 within a patient's reproductive lumen 35 in an expanded configuration.
  • Tissue growth 36 is shown within the mesh member 33 disposed at the open end 37 of the occluding component 11.
  • the embodiment illustrated in Figures 6-9 depicts the mesh member 32 as a single layer of woven filaments or strands 33 and 34, disposed across the opening 37 with one or more wires within the mesh member providing galvanic effect between themselves or in conjunction with the metallic material of the occluding component 31.
  • the mesh member 32 may be formed of a plurality of layers with the individual layers having the same or different mesh sizes.
  • Galvanic action may be generated in the embodiment with the multilayered mesh member between the different layers, within the layers themselves and between the layers and the metallic material of the occluding component.
  • the individual layers of the mesh member may be separated by layers of insulating material.
  • the mesh member 30 is shown as being woven or braided to simplify the drawings. However, the member 30 may be in the form of a fibrous matt or other fibrous or porous construction.
  • a variety of biocompatible non-metallic materials may be used to form the mesh members 33 and 34 including polymers and treated animal tissues, e.g Dacron, Nylon, heterologous tissue, such as porcine or bovine pericardial tissue, which promote tissue growth, whereas the occluding component is constructed to provide galvanic electrical stimulation to encourage cell proliferation and thus tissue ingrowth by itself or in conjunction with one or more metallic strands in the mesh members 33 and 34.
  • the strands 33 and/or 34 of the mesh member 32 may be coated or otherwise impregnated with cell growth stimulators, hormones, and/or chemicals to enhance tissue impregnation.
  • the strands used to form the mesh member 32 are generally about 0.00025 mm to about 0.25 mm in diameter.
  • the mesh member 32 may have a mesh size of about 5 ⁇ m to about 0.05 mm, and preferably about 10 ⁇ m to about 15 ⁇ m.
  • mesh members having relatively large mesh sizes are coated with the epithelialization promoter agents.
  • Figures 10 and 11 illustrate an embodiment having features of the invention which has an occluding device 40 (similar to that shown in Figures 6-9) having an occluding component 41 with a fibrous mass 42 provided within the inner lumen 43 of the occluding component and a fibrous jacket or sock 44 that extends along at least a section of the outer surface of the occluding component 41 and over an open end 45 of the occluding component 41.
  • the fibrous material on the exterior, interior and an open end ensures more widespread tissue growth for occlusion.
  • the portion 46 of the fibrous jacket or sock 44 may be formed integral or separate from the portion 47 of the fibrous jacket which extends over the open end 45.
  • Galvanic activity may be generated between metallic strands in the jacket 44, between metallic strands in the jacket 44 and metallic strands within the fibrous body 42 within inner lumen 43 or metallic strands within either the fibrous body 42 or the jacket or sock 44 or both and the occluding component.
  • the fibrous material of the fibrous body 42 and that of the jacket or sock 44 are permeable to allow for tissue ingrowth when the occluding component 41 is expanded into contact with a wall of the reproductive lumen 46 as shown schematically in Figure 11.
  • the occluding component 41 is preferably self expanded within the reproductive lumen 48 due to the presence of the fibrous body 42 within the inner lumen 43.
  • Figures 12-14 illustrate an alternative occluding device 50 embodying features of the invention and having a tubular, stent-like occluding component 51 in the form of a metallic hypotube 52 with slots 53 cut into the wall of the hypotube to allow expansion of the occluding component to an expanded configuration with larger transverse dimensions as shown in Figure 13.
  • a rod or wire 54 is longitudinally disposed within the inner lumen 55 of the occluding component 51.
  • the galvanic activity may be created by constructing all or part of the occluding component 51 of one metal and the rod or wire 54 disposed within the inner lumen 55 of the occluding component formed of a different metal.
  • the occluding component 51 may optionally have barbed or hook like projections 56 that aid in retention of the occluding component 51 within a reproductive lumen. While the projections 56 are shown in Figure 13 inclined toward one end of the occluding component, they may be inclined toward either or both ends of the occluding component.
  • the metal rod or wire 54 may be suspended within a fibrous body 57 as shown in Figure 14.
  • the fibrous body 57 may be formed of metallic or non-metallic strands 58, e.g. polyethylene terephthalate (PET). These fibrous strands 58 may be formed of insulating material to isolate the rod or wire 54 from the occluding component 51. However, the fibrous body 57 may have one or more metallic strands which are formed of different metallic material from either the rod or wire 54 or the occluding component 51.
  • PET polyethylene terephthalate
  • FIG. 15 illustrates an alternative occluding device 60 having features of the invention.
  • the occluding device 60 comprises an occluding component 61 formed into a helically shaped coil 62 of a first metallic material with space 63 between individual turns of the helically shaped coil.
  • a second helically shaped coil 64 formed of a second metallic material different from the first metallic material is fitted into the space 63 of the first coil 62 to generate galvanic activity to enhance tissue growth into and/or on the occluding component 61.
  • the contacting surfaces of the helically shaped coils 62 and 64 may be insulated (not shown) to varying degrees to control the level of galvanic activity to achieve the desired tissue ingrowth.
  • a fibrous body may be disposed within the inner lumen 65 of the occluding component 61 or a fibrous jacket or sock (such as shown in Figures 10 and 11 ) may be provided on the exterior of the occluding component to further enhance tissue growth.
  • the helical coils 62 and 64 may be balloon or self expandable for deployment within a patient's body lumen.
  • FIG. 16 Another occluding device 70 embodying features of the invention is depicted in Figure 16, which has an occluding component 71 formed of a helically shaped coil structure 72 similar to the occluding component 61 shown in Figure 15 and a smaller diameter helical coil 73 disposed within the inner lumen 74 of the occluding component 71.
  • the occluding component 71 is expandable and preferably is formed of shape memory or superelastic metallic material such as NiTi alloy like NITINOL.
  • the helically shaped coil 72 may be suspended within the inner lumen 73 by a mesh or other fibrous body (not shown) such as discussed above and shown in Figure 14.
  • the inner coil 72 may be formed of metallic material different from the metallic material of the occluding component to generate galvanic activity which stimulates tissue growth into and onto the occluding component 71 of device 70.
  • the strands of a fibrous body disposed within the inner lumen 73 may be metallic strands and add to the electrical activity.
  • FIG. 17 Another occluding device 80 embodying features of the invention is shown in Figure 17.
  • the occluding device 80 has an occluding component 81 having two layers 82 and 83 formed of different metals rolled together. There may be a layer of insulative material between the two metal layers (not shown) to enhance the galvanic effects and to localize the ionic exchange to the edges of the occluding component 81.
  • the occluding device 90 of this embodiment has an occluding component 91 which is a tubular element 92 that may or may not be expandable against the walls of the body lumen with particles 93 and 94 formed of different metallic material on the surface of the tubular member.
  • the tubular element 92 is generally an insulator, and when the device is implanted in a reproductive lumen and in contact with body fluids which act as electrolytes, a voltage differential exists between the different metal particles which is sufficient to encourage tissue ingrowth to occur, and to thus enhance the occlusion of the reproductive lumen into which the occluding device 90 is deployed.
  • a voltage may be impressed against the tissue of a reproductive lumen such as a fallopian tube or vas deferens to enhance tissue growth into or onto an occluding device deployed within the reproductive lumen such as described herein.
  • a suitable occluding device 100 is shown in Figures 19 and 20. As shown in Figure 19 the suitable occluding device 100 comprises an occluding component 101 formed of four separate interfitting helical coils 102, 103, 104 and 105. Helical coils 102 and 104 are electrically connected by conductors 106 and 107 respectively to opposite poles 108 and 109 of a power source 110 (e.g. battery).
  • a power source 110 e.g. battery
  • the helical coils 102 and 104 act as electrodes.
  • Helical coils 103 and 105 are insulators. In this way the two helical coils 102 and 104 are insulated from each other along their length, and conduct electrical current to each other through the tissue in contact with metallic portions of the occluding component 101.
  • Figure 20 illustrates the occluding device 100 deployed within a patient's fallopian tube 111.
  • the conductors 106 and 107 extend through the patient's uterine cavity 112 and vaginal canal 113 and are electrically connected to battery 110.
  • the application of electrical power from the external source 110 is usually intermittent. For example, electrical power from the battery 110 can be applied for about one hour a day for the first five days and may only be needed to stimulate initial tissue ingrowth. This may be monitored and the application of the electrical power discontinued when the tissue ingrowth is sufficiently complete. This electrical stimulation is very helpful in initiating effective tissue ingrowth at the inception of the implantation of the occlusive device. Essentially the same basic system may be employed to occlude a male reproductive lumen such as a vas deferens.
  • FIG. 21 Another occluding device 130 is shown in Figure 21 which has features of the invention.
  • the occluding device 130 has an occluding component 131 with an elongated shaft 132 and spider-like expandable elements 133, 134 and 135.
  • the expandable elements are formed of different metallic materials than the expandable element adjacent thereto to provide the desired galvanic activity.
  • the junctions between the portions of differing metallic materials are shown at locations 136 and 137.
  • the junctions 136 and 137 may be formed mechanically, metallurgically, adhesively, by laser welding. In those situations in which the portions of the shaft are difficult to join, a cylindrical collar may be employed to joint the mating ends of the shaft sections.
  • the occluding component 131 may be formed entirely of a first metallic material and a collar 138 formed of a second different metallic material may be secured to one or more of the expandable legs 139 of expandable spider-like element 135 or the shaft 132 to provide the galvanic activity required to enhance tissue growth.
  • One or more of the spider-like elements 133-135 may have a fibrous member (not shown) such as shown in Figure 5.
  • Various means may be employed to secure an occluding device embodying features of the invention within a reproductive or other lumen other than as described above.
  • mechanical, adhesive or other anchoring means may be employed to secure the expanded occluding device to the vessel wall defining the body lumen.
  • the occluding component of devices embodying features of the invention are preferably formed of a superelastic material such as NiTi alloy so as to provide a controlled force on the body lumen during expansion. Additionally, the surface of the occluding components may be configured to further facilitate epithelial and other tissue ingrowth. Suitable surface treatments include plasma etching, sand blasting, machining and other treatments to roughen the surface. The surface of the occluding component may be coated or seeded to spur epithelialization. [0060]
  • the fibrous and mesh members may be connected to the occluding component by a variety of suitable means including tying, sutures, clips, adhesives, heat bonding, or solvent bonding.
  • the occluding device may be used to occlude a variety of body lumens or passageways such as arteries or veins in a variety of situations, the nidus of an arterial-venous malformation, patent ductus arteriosis in infants, as well as arteries leading to benign or cancerous tumors.

Abstract

This invention is directed to occluding devices and methods of using such devices for occluding a patient’s body lumen, such as a reproductive lumen for contraceptive purposes. The occluding device generally has an occluding component (11), a first metallic element (16) associated with the occluding component, a second metallic element (17) associated with the occluding component. The first and second metallic elements are configured to generate electrical activity which enhances tissue growth into and/or onto the occluding component to aid in lumen occlusion. In one embodiment the first and second metallic elements are formed of different metallic materials and generate galvanic activity. In a second embodiment electrical power is applies to the first and second metallic elements to generate electrical activity that enhances tissue growth.

Description

ENHANCING TISSUE INGROWTH FOR CONTRACEPTION
BACKGROUND OF THE INVENTION [0001] This invention generally relates to the field of occluding devices, delivery systems for such devices and the method of using such devices and systems in the occlusion of body passageways. The invention is particularly useful for the occluding reproductive lumens such as a female patient's fallopian tubes or a male patient's vas deferens to affect contraception.
[0002] Conventional contraceptive strategies generally fall within three categories: physical barriers, drugs and surgery. While each have certain advantages, they also suffer from various drawbacks. Barriers such as condoms and diaphragms are subject to failure due to breakage, displacement and misplacement. Drug strategies, such as the pill and Norplant™, which rely on artificially controlling hormone levels, suffer from known and unknown side-effects from prolonged use. Surgical procedures, such as tubal ligation and vasectomy, are very effective, but involve the costs and attendant risks of surgery, and are frequently not reversible.
[0003] Recently, minimally invasive treatments have be proposed which deploy stent-like devices within reproductive lumens for obstructing such lumens as a contraceptive alternative to tubal ligation. However, placing a stent alone or a stent with fibrous material or similar occluding device may not create sufficient or permanent obstruction of the reproductive lumen depending on the nature of the obstructive device. For example, the obstructive device may be too small to provide complete obstruction of the reproductive lumen, or the device may be permeable to cell movement. An occluding device placed in a reproductive lumen, for example, may not securely seal against the luminal walls, or may initially allow egg cells or sperm cells to pass through the device until tissue growth completes the occlusion of the reproductive lumen and thus allow pregnancy to occur. Additionally, the occluding device might create an obstruction sufficient to prevent the passage of an egg but allow sperm cells to pass through or by the occluding device, fertilizing an egg upstream of the obstruction and resulting in an ectopic pregnancy. [0004] The use of an occluding contraceptive or sterilization device, particularly with mesh or fibrous material to promote tissue ingrowth, has been proposed (See for example U.S. Patent No. 6,432,116). However, with these devices there is an initial period after deployment during which the patient is at risk for cell passage through the device and which can result in pregnancy. SUMMARY OF THE INVENTION [0005] The present invention provides an improved devices and methods of using such devices for occluding body lumens, particularly reproductive lumens for contraceptive purposes. As used herein, tissue growth includes but is not limited to cell multiplication and/or growth resulting in tissue formation into, onto, or surrounding an occluding device. The tissue growth may be epithelialization, scar formation, or other cell growth or multiplication.
[0006] An occluding device having features of the invention generally includes an occluding component which is configured to expand within the body lumen to be occluded and first and second metallic elements which are associated with the occluding component and which are configured to generate electrical activity within a patient's body lumen to enhance the growth of tissue into or onto the occluding component of the occluding device.
[0007] In one embodiment having features of this invention, the occluding device has a occluding component and has two metallic components formed of different metallic material and electrically connected to effect galvanic activity when the occluding device contacts body fluid or other conductive fluid to stimulate cellular growth into or on the occluding component of the device. One or both of the metallic elements may be part of the occluding device or separate elements directly or indirectly attached to the occluding device.
[0008] In another embodiment having features of the invention, the occluding device has a occluding component and has two separate metallic components which are configured to be electrically connected to an electrical power source (e.g. a battery or other low voltage source) to generate the electrical activity sufficient to stimulate cell growth onto or within the occluding component of the device. When the occluding device is deployed within a body lumen and contacts body fluid or other electrically conductive fluid (e.g. saline) therein which acts as an electrolyte, cell growth into or onto the occluding component is stimulated to enhance attachment of the device within the body lumen and occlusion of the lumen. [0009] One particularly useful application for occluding devices embodying features of the invention is directed to occluding a reproductive lumen such as a fallopian tube or a vans deferens for contraceptive purposes. In some situations, one of the metallic elements or one group of the metallic elements configured for developing electrical activity in the body lumen, may be formed of copper to provide further contraceptive action in addition to the occlusion of the lumen. Additionally, therapeutic or diagnostic agents by be employed with the occluding device for contraceptive or other uses, e.g. antibiotics, chemotherapy. For example, the occluding component can be coated with a polymer having impregnated therein an agent such as a drug, enzyme or protein, for inducing or promoting tissue growth. In yet another refinement, the surface of the occluding component may be plated with or otherwise incorporated with an elutable inflammatory material to produce an inflammatory response in the tissue of the wall defining the body lumen, which further contributes to the obstruction of the lumen. Inflammatory materials include copper or copper alloys. Other inflammatory materials, such as radioactive materials (emitting alpha, beta or gamma particles) may be used alone or in conjunction with other inflammatory materials. [0010] The occluding device embodying features of the invention preferably has an occluding component that at least in part has a first delivery configuration with small transverse dimensions suitable for delivery to the chosen location in a reproductive or other body lumen and a second expanded configuration larger in transverse dimensions than the first configuration to facilitate securing the occluding component of the device within the reproductive or body lumen. The occluding component of the device may be balloon expandable or self-expandable from the first configuration to the second configuration to occlude the body lumen. [0011] The occluding device may be a tubular stent-like structure, such as described in U.S. Patent Applications Serial Nos. 08/770,123, filed on December 18, 1996, 09/112,085, filed on July 8, 1998, 09/468,749, filed on December 21 , 1999 and U.S. Provisional Application Serial No. 60/483,587, filed on June 27, 2003. Alternatively, the occluding device may have one or more spider-like constructions shown in co-pending application Serial No. 10/746,131 , filed on December 24, 2003. The occluding component will generally be about 1 to about 5 mm, preferably about 2 to about 4 mm in transverse dimension in the expanded configuration and will generally be about 0.5 to about 8 cm, preferably about 1.5 to about 4 cm in length. While the description herein is focused on the use of only one occluding device, two or more occluding devices may be employed in a reproductive or other body lumen. [0012] The occluding device having features of the invention is placed in a contracted configuration to facilitate introduction and advancement of the device within the reproductive lumen or other body lumen, usually within an inner lumen of a delivery sheath. Once in the desired position within a patient's body lumen, the delivery sheath is withdrawn while the occluding device is held in-place at the desired location. The sheath withdrawal exposes the occluding device at the chosen site and the occluding device is expanded either by inflating a balloon within the inner lumen of the occluding component or from self expansion due to the nature and condition of the metallic material of which the occluding component is made. An exposed portion of the occluding device may expand or be expanded before the entire occluding device is discharged from the delivery sheath. Self-expanding occluding components of the device may be formed of superelastic NITINOL with an austenite phase that is stable at body temperature, i.e. the material of the occluding component will not transform from the austenite phase to a martensite phase at body temperature except by the application of stress. The occluding component may also be formed of a heat expandable metallic material such as shape memory NITINOL which has a stable martensite phase at body temperature and which returns to a remembered expanded condition when heated above the martensite-to-austenite transition temperature causing the occluding component to expand within the patient's body lumen.
[0013] The metallic elements associated with the occluding component and which generate the electrical activity within the body lumen to stimulate tissue growth may be formed at least in part of suitable conductive metallic materials such as stainless steel, NiTi alloy, platinum, tantalum, copper and gold. Other conductive materials are suitable. Moreover, the metallic elements may be part of the occluding component or be separate elements which are directly or indirectly secured to the occluding component. They may be electrically connected through one or more electrical conductors or even the occluding component itself. [0014] Fibrous strands or bundles thereof, fibrous mesh, porous polymer bodies and the like may be disposed within or on the occluding device to facilitate tissue ingrowth in addition to the electrical stimulation of tissue growth. The fibrous bundle, fibrous mesh or porous polymeric bodies may be disposed in either balloon expandable or self-expanding occluding devices. However, mesh, fibrous or porous polymeric material within the inner lumen of balloon expandable occluding components can make balloon placement within the inner lumen difficult. [0015] To generate the electrical activity, in general, two different metal elements which are electrically connected are immersed in an electrolyte, such as body fluids or saline or both to stimulate tissue growth. The body fluid in which the occlusive device is generally immersed, such as the moist tissue and surface within reproductive lumens may frequently suffice to create the electrical activity of minimal magnitude required for these purposes. Additional conductive fluid such as saline may be provided within the body lumen if needed to facilitate the desired electrical application.
[0016] These and other advantages of the invention will become more apparent from the following detailed description of embodiment having features of the invention, taken in conjunction with the accompanying exemplary drawings. BRIEF DESCRIPTION OF THE DRAWINGS [0017] Figure 1 is an elevational view of an occluding device embodying features of the invention with an occluding component in a first, contracted configuration.
[0018] Figure 2 is a transverse cross sectional view of the device shown in
Figure 1 , taken along lines 2-2.
[0019] Figure 3 is an elevational view of the device shown in Figure 1 , in a second, expanded configuration.
[0020] Figure 4 is a transverse cross sectional view of the device shown in
Figure 3, taken along lines 4--4.
[0021] Figure 5 is an elevational view of an alternative occluding device embodying features of the invention having bundles of fibrous strands intermittently spaced in a plurality of sections within the inner lumen of the occluding component. [0022] Figure 6 is an elevational view of another alternative occluding device embodying features of the invention having a fibrous mesh of woven strands disposed at one end of the occluding component.
[0023] Figure 7 is a partial end view of the fibrous mesh shown in Figure 6.
[0024] Figure 8 is a longitudinal cross sectional view of the occluding device shown in Figure 6, disposed within a body lumen and illustrating tissue growth into and on the occluding component.
[0025] Figure 9 is a transverse cross sectional view of the device shown in
Figure 8, taken along lines 9-9.
[0026] Figure 10 illustrates another alternative occluding device embodying features of the invention which is disposed in an unexpanded configuration within a body lumen and which has a fibrous jacket or sock on an outer surface of the occluding component.
[0027] Figure 11 illustrates the device shown in FIG. 10 in an expanded configuration.
[0028] Figure 12 is an elevational view of an occluding device embodying features of the invention with a metallic rod within the interior of the occluding component in an unexpanded configuration.
[0029] Figure 13 is an elevational view of an occlusive device of Figure 12 in its expanded configuration.
[0030] Figure 14 is a transverse cross-sectional view of a modification of the occluding device with the inner rod or wire deployed within a fibrous body in the interior of the occluding component.
[0031] Figure 15 illustrates an occluding device embodying features of the invention having a helically shaped occluding component and a helically shaped member of different metallic composition which interfits within the spacing between the turns of the helically shaped occluding component.
[0032] Figure 16 illustrates an occluding device embodying features of the invention comprising an occluding component as shown in Figure 15 with a tightly coiled helical member within the inner lumen of the occluding component.
[0033] Figure 17 is an isometric view of an alternative occluding device comprising two sheets of metal sheet or foil formed of different metals;
[0034] Figure 18 is an isometric view of an alternative occluding device having granules of different metals on its surface; [0035] Figure 19 is a schematic view of a female reproductive anatomy with the occluding device embodying features of the invention configured for deployment within a female patient's fallopian tube.
[0036] Figure 20 is an elevational view partially is section of the occluding device shown in Figure 19 disposed within the fallopian tube of a female patient and which has an external electrical source.
[0037] Figure 21 is a perspective view of an alternative occluding device having an occluding component with several spider-like members disposed along the supporting shaft. DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION [0038] Figures 1-4 schematically illustrate an occluding contraceptive device
10 embodying features of the invention that generally includes an expandable stent- like occluding component or structure 11 having a first open end 12, a second open end 13, a lumen 14 extending therein and a fibrous member 15 within the inner lumen extending along a substantial length thereof. Figures 1 and 2 depict the device 10 in a delivery configuration for introduction into and advancement within the patient's reproductive lumen. Figures 3 and 4 depict the device in an expanded configuration.
[0039] As best shown in Figure 2, a fibrous member 15 is transversely disposed in the occluding structure 11. In this embodiment, in order to electrically stimulate tissue growth into or onto the occluding component 11 , woven or interspersed wire element 16 is formed of one metallic material and woven or interspersed wire element 17 is formed of a second different metallic material. The metallic wires generate sufficient galvanic activity with respect to the first metallic material to stimulate tissue growth when disposed within a patient's body lumen and in contact with a body or other conductive fluid. For example, wire 16 may be made of stainless steel and wire 17 may be made of copper. While the galvanic activity generated by stainless steel and copper are very slight, the mild electrical conditions generated are sufficient to stimulate tissue ingrowth into or onto the occluding component. As previously mentioned, the copper wires 17 not only generate a galvanic response, but can provide contraceptive effects. To simplify the drawings only the two metallic strands 16 and 17 are shown. The fibrous member 15 may have a plurality of biocompatible, non-metallic strands (e.g. PET, nylon, Hytrel) to facilitate cellular growth to augment that provided by the galvanic activity. [0040] As illustrated in Figure 4, the fibrous member 15 may be configured to expand when the occluding device 10 is expanded to the expanded configuration, so that the fibrous member 15 extends across the expanded lumen 14. The stent-like occluding component 11 has an open, lattice-type structure facilitating tissue ingrowth through the wall thereof in the expanded configuration that facilitates securing the occluding component to the wall defining the reproductive lumen as well as occluding the reproductive lumen. Preferably, the occluding component 11 is of a diameter which is about equal to or slightly larger than the dimensions of the reproductive lumen within which the contraceptive device 10 is to be disposed. For example, for deployment within a female patient's fallopian tubes, the expanded transverse dimensions may be about 0.05 mm to about 5 mm, preferably about 0.1 to about 3 mm.
[0041] The fibrous member 15 is permeable to facilitate epithelialization or other tissue ingrowth, and the complex comprising the fibrous member with the tissue ingrowth occludes the reproductive lumen sufficiently to prevent the passage of reproductive cells therethrough. [0042] Alternatively, the metallic strands forming in part the fibrous member
15, e.g. 16 and 17, may be formed of the same metallic material and in contact with the occluding component 11 which is formed of a different metallic material to generate sufficient galvanic activity to stimulate tissue growth. [0043] In an alternative embodiment illustrated in FIG. 5, an occluding device
20 has an occluding component 21 (similar to that shown in Figure 1 ) with a plurality of fibrous members 22, 23 and 24 disposed within the inner lumen 25 of occluding component 21. The individual fibrous members 22-24 are spaced along the length of the tubular occluding component 21 with fibrous member 22 and 23 being within the ends of the occluding component and fibrous member 24 being centrally spaced. Three fibrous members 22-24 are illustrated but a greater or lesser number of fibrous members may be disposed within the inner lumen 25. As discussed above, the individual filaments or strands of a single fibrous member may be formed of different metallic material, the metallic filaments of one fibrous member may be different metallic material from the metallic filaments of an adjacent fibrous member or the metallic filaments of one or more of the fibrous members may be formed of metallic material different from the metallic material of the occluding component 21 in order to develop sufficient galvanic activity to stimulate tissue growth into or onto the device 10.
[0044] Additional, the occluding component 21 may have one tubular section
26 formed of a different metallic material than tubular section 27 thereof. In this construction, the filaments of the mesh members may be formed of metallic material different from the metallic material of one or both of the tubular sections 23 and 24 to vary the galvanic activity along the length of the occluding component when disposed in body fluids or other electrically conductive fluids. While not shown, the tubular segments 26 and 27 may be separated and insulated by fibrous members disposed therebetween.
[0045] Figures 6 and 7 illustrate an occluding device 30 having an occluding component 31 with a permeable mesh member 32 formed of a plurality of woven strands 33 and 34 which extend across open end 35 of the occluding component 31 and facilitate tissue growth and occlude a body lumen into which the occluding device is deployed. Some or all of the woven strands 33 may be formed of a first metallic material and some or all of woven strands 34 may be formed of a metallic material different from that of strands 33. As discussed above, the metallic strands 33 or 34 of mesh member 32 may be formed of a metallic material different from the metallic material of the occluding component 31 .
[0046] Figure 7 is an end view of the device illustrated in Figure 6, illustrating the woven strands 33 and 34 forming the mesh member 32. However, the mesh member 32 may comprise a variety of suitable permeable structures which support tissue growth. For example, the mesh member 32 may be replaced with a foamed porous membrane formed of biocompatible materials. The electrical activity stimulates and enhances tissue growth as described above.
[0047] Figures 8 and 9 schematically illustrate the occluding device 30 shown in Figures 6 and 7 within a patient's reproductive lumen 35 in an expanded configuration. Tissue growth 36 is shown within the mesh member 33 disposed at the open end 37 of the occluding component 11. For purposes of simplicity, the embodiment illustrated in Figures 6-9 depicts the mesh member 32 as a single layer of woven filaments or strands 33 and 34, disposed across the opening 37 with one or more wires within the mesh member providing galvanic effect between themselves or in conjunction with the metallic material of the occluding component 31. The mesh member 32 may be formed of a plurality of layers with the individual layers having the same or different mesh sizes. Galvanic action may be generated in the embodiment with the multilayered mesh member between the different layers, within the layers themselves and between the layers and the metallic material of the occluding component. The individual layers of the mesh member may be separated by layers of insulating material. The mesh member 30 is shown as being woven or braided to simplify the drawings. However, the member 30 may be in the form of a fibrous matt or other fibrous or porous construction.
[0048] A variety of biocompatible non-metallic materials may be used to form the mesh members 33 and 34 including polymers and treated animal tissues, e.g Dacron, Nylon, heterologous tissue, such as porcine or bovine pericardial tissue, which promote tissue growth, whereas the occluding component is constructed to provide galvanic electrical stimulation to encourage cell proliferation and thus tissue ingrowth by itself or in conjunction with one or more metallic strands in the mesh members 33 and 34. Additionally, the strands 33 and/or 34 of the mesh member 32 may be coated or otherwise impregnated with cell growth stimulators, hormones, and/or chemicals to enhance tissue impregnation. The strands used to form the mesh member 32 are generally about 0.00025 mm to about 0.25 mm in diameter. It would be obvious that a wide variety of mesh sizes that support tissue growth may be used. For example, in one embodiment the mesh member 32 may have a mesh size of about 5 μm to about 0.05 mm, and preferably about 10 μm to about 15 μm. Preferably, mesh members having relatively large mesh sizes are coated with the epithelialization promoter agents.
[0049] Figures 10 and 11 illustrate an embodiment having features of the invention which has an occluding device 40 (similar to that shown in Figures 6-9) having an occluding component 41 with a fibrous mass 42 provided within the inner lumen 43 of the occluding component and a fibrous jacket or sock 44 that extends along at least a section of the outer surface of the occluding component 41 and over an open end 45 of the occluding component 41. The fibrous material on the exterior, interior and an open end ensures more widespread tissue growth for occlusion. The portion 46 of the fibrous jacket or sock 44 may be formed integral or separate from the portion 47 of the fibrous jacket which extends over the open end 45. Galvanic activity may be generated between metallic strands in the jacket 44, between metallic strands in the jacket 44 and metallic strands within the fibrous body 42 within inner lumen 43 or metallic strands within either the fibrous body 42 or the jacket or sock 44 or both and the occluding component. The fibrous material of the fibrous body 42 and that of the jacket or sock 44 are permeable to allow for tissue ingrowth when the occluding component 41 is expanded into contact with a wall of the reproductive lumen 46 as shown schematically in Figure 11. The occluding component 41 is preferably self expanded within the reproductive lumen 48 due to the presence of the fibrous body 42 within the inner lumen 43. [0050] Figures 12-14 illustrate an alternative occluding device 50 embodying features of the invention and having a tubular, stent-like occluding component 51 in the form of a metallic hypotube 52 with slots 53 cut into the wall of the hypotube to allow expansion of the occluding component to an expanded configuration with larger transverse dimensions as shown in Figure 13. In this construction, a rod or wire 54 is longitudinally disposed within the inner lumen 55 of the occluding component 51. The galvanic activity may be created by constructing all or part of the occluding component 51 of one metal and the rod or wire 54 disposed within the inner lumen 55 of the occluding component formed of a different metal. The occluding component 51 may optionally have barbed or hook like projections 56 that aid in retention of the occluding component 51 within a reproductive lumen. While the projections 56 are shown in Figure 13 inclined toward one end of the occluding component, they may be inclined toward either or both ends of the occluding component. The metal rod or wire 54 may be suspended within a fibrous body 57 as shown in Figure 14. The fibrous body 57 may be formed of metallic or non-metallic strands 58, e.g. polyethylene terephthalate (PET). These fibrous strands 58 may be formed of insulating material to isolate the rod or wire 54 from the occluding component 51. However, the fibrous body 57 may have one or more metallic strands which are formed of different metallic material from either the rod or wire 54 or the occluding component 51.
[0051] Figure 15 illustrates an alternative occluding device 60 having features of the invention. In this embodiment the occluding device 60 comprises an occluding component 61 formed into a helically shaped coil 62 of a first metallic material with space 63 between individual turns of the helically shaped coil. A second helically shaped coil 64 formed of a second metallic material different from the first metallic material is fitted into the space 63 of the first coil 62 to generate galvanic activity to enhance tissue growth into and/or on the occluding component 61. The contacting surfaces of the helically shaped coils 62 and 64 may be insulated (not shown) to varying degrees to control the level of galvanic activity to achieve the desired tissue ingrowth. As previously described, a fibrous body (not shown) may be disposed within the inner lumen 65 of the occluding component 61 or a fibrous jacket or sock (such as shown in Figures 10 and 11 ) may be provided on the exterior of the occluding component to further enhance tissue growth. The helical coils 62 and 64 may be balloon or self expandable for deployment within a patient's body lumen. [0052] Another occluding device 70 embodying features of the invention is depicted in Figure 16, which has an occluding component 71 formed of a helically shaped coil structure 72 similar to the occluding component 61 shown in Figure 15 and a smaller diameter helical coil 73 disposed within the inner lumen 74 of the occluding component 71. The occluding component 71 is expandable and preferably is formed of shape memory or superelastic metallic material such as NiTi alloy like NITINOL. The helically shaped coil 72 may be suspended within the inner lumen 73 by a mesh or other fibrous body (not shown) such as discussed above and shown in Figure 14. The inner coil 72 may be formed of metallic material different from the metallic material of the occluding component to generate galvanic activity which stimulates tissue growth into and onto the occluding component 71 of device 70. The strands of a fibrous body disposed within the inner lumen 73 may be metallic strands and add to the electrical activity.
[0053] Another occluding device 80 embodying features of the invention is shown in Figure 17. In this embodiment, the occluding device 80 has an occluding component 81 having two layers 82 and 83 formed of different metals rolled together. There may be a layer of insulative material between the two metal layers (not shown) to enhance the galvanic effects and to localize the ionic exchange to the edges of the occluding component 81.
[0054] Yet another construction embodying features of the invention is shown in Figure 18. The occluding device 90 of this embodiment has an occluding component 91 which is a tubular element 92 that may or may not be expandable against the walls of the body lumen with particles 93 and 94 formed of different metallic material on the surface of the tubular member. The tubular element 92 is generally an insulator, and when the device is implanted in a reproductive lumen and in contact with body fluids which act as electrolytes, a voltage differential exists between the different metal particles which is sufficient to encourage tissue ingrowth to occur, and to thus enhance the occlusion of the reproductive lumen into which the occluding device 90 is deployed.
[0055] In addition to the stimulation of tissue growth by galvanic activity as discussed above, a voltage may be impressed against the tissue of a reproductive lumen such as a fallopian tube or vas deferens to enhance tissue growth into or onto an occluding device deployed within the reproductive lumen such as described herein. A suitable occluding device 100 is shown in Figures 19 and 20. As shown in Figure 19 the suitable occluding device 100 comprises an occluding component 101 formed of four separate interfitting helical coils 102, 103, 104 and 105. Helical coils 102 and 104 are electrically connected by conductors 106 and 107 respectively to opposite poles 108 and 109 of a power source 110 (e.g. battery). The helical coils 102 and 104 act as electrodes. Helical coils 103 and 105 are insulators. In this way the two helical coils 102 and 104 are insulated from each other along their length, and conduct electrical current to each other through the tissue in contact with metallic portions of the occluding component 101.
[0056] Figure 20 illustrates the occluding device 100 deployed within a patient's fallopian tube 111. The conductors 106 and 107 extend through the patient's uterine cavity 112 and vaginal canal 113 and are electrically connected to battery 110. The application of electrical power from the external source 110 is usually intermittent. For example, electrical power from the battery 110 can be applied for about one hour a day for the first five days and may only be needed to stimulate initial tissue ingrowth. This may be monitored and the application of the electrical power discontinued when the tissue ingrowth is sufficiently complete. This electrical stimulation is very helpful in initiating effective tissue ingrowth at the inception of the implantation of the occlusive device. Essentially the same basic system may be employed to occlude a male reproductive lumen such as a vas deferens.
[0057] Another occluding device 130 is shown in Figure 21 which has features of the invention. The occluding device 130 has an occluding component 131 with an elongated shaft 132 and spider-like expandable elements 133, 134 and 135. The expandable elements are formed of different metallic materials than the expandable element adjacent thereto to provide the desired galvanic activity. The junctions between the portions of differing metallic materials are shown at locations 136 and 137. The junctions 136 and 137 may be formed mechanically, metallurgically, adhesively, by laser welding. In those situations in which the portions of the shaft are difficult to join, a cylindrical collar may be employed to joint the mating ends of the shaft sections. Alternatively, the occluding component 131 may be formed entirely of a first metallic material and a collar 138 formed of a second different metallic material may be secured to one or more of the expandable legs 139 of expandable spider-like element 135 or the shaft 132 to provide the galvanic activity required to enhance tissue growth. One or more of the spider-like elements 133-135 may have a fibrous member (not shown) such as shown in Figure 5. [0058] Various means may be employed to secure an occluding device embodying features of the invention within a reproductive or other lumen other than as described above. For example, mechanical, adhesive or other anchoring means may be employed to secure the expanded occluding device to the vessel wall defining the body lumen. Means to secure a stent or prosthetic device to an aortic or arterial wall, such as described in U.S. Pat. No. 4,140,126; U.S. Pat. No. 4,562,596; U.S. Pat. No. 4,577,631 ; U.S. Pat. No. 4,787,899; U.S. Pat. No. 5,104,399; U.S. Pat. No. 5,167,614; U.S. Pat. No. 5,275,622; U.S. Pat. No. 5,456,713; and U.S. Pat. No. 5,489,295 may be useful in this regard.
[0059] The occluding component of devices embodying features of the invention are preferably formed of a superelastic material such as NiTi alloy so as to provide a controlled force on the body lumen during expansion. Additionally, the surface of the occluding components may be configured to further facilitate epithelial and other tissue ingrowth. Suitable surface treatments include plasma etching, sand blasting, machining and other treatments to roughen the surface. The surface of the occluding component may be coated or seeded to spur epithelialization. [0060] The fibrous and mesh members may be connected to the occluding component by a variety of suitable means including tying, sutures, clips, adhesives, heat bonding, or solvent bonding.
[0061] Various modifications and improvements may be made to the present invention without departing from the scope thereof. For example, while the invention has been discussed primarily in terms of occluding a reproductive body lumen, the occluding device may be used to occlude a variety of body lumens or passageways such as arteries or veins in a variety of situations, the nidus of an arterial-venous malformation, patent ductus arteriosis in infants, as well as arteries leading to benign or cancerous tumors.
[0062] Additionally, other occluding devices and delivery devices that may be utilized are disclosed in Patent Applications Serial Number 08/770,123, filed on December 18, 1996, Serial No. 09/112,085, filed on July 8, 1998, Serial No. 09/468,749, filed on December 21 , 1999, Serial No. 10/746,131 , filed on December 24, 2004 and Provisional Application Serial No. 60/483,587, filed on June 27, 2003. [0063] Although individual features of the invention may be described with respect to one or more of the embodiments but not in other embodiments, it should be readily apparent that individual features of one embodiment having features of the invention can be combined with any or all the features of one or more of other embodiments.
[0064] Terms such a "element", "member", "device", "section", "portion",
"component", "means", "step" and words of similar import, when used in the following claims, shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the claims expressly use the term "means" followed by a particular function without specific structure or expressly use the term "step" or "steps" followed by a particular function without specific action. The full disclosures of all patents and patent applications referred to herein are incorporated by reference.

Claims

What is claimed:
1. A contraceptive device for occluding a patient's reproductive lumen, comprising: a. an expandable occluding component; b. a first element which is associated with the occlusion component and which is formed at least in part of a first metallic material; and c. a second element which is associated with the occlusion component, which is formed at least in part of a second metallic material different from the first metallic material; and d. an electrical connection between the first and second metallic elements configured to generate sufficient electrical activity between the first and second metallic elements to stimulate tissue growth within the reproductive lumen when in contact with conductive fluid within the reproductive lumen.
2. The device of claim 1 wherein the tissue growth is into the occluding component.
3. The device of claim 1 wherein the tissue growth is onto the occluding component.
4. The device of claim 1 wherein the occluding component is a stent.
5. The device of claim 4 wherein at least one of the first or second elements are formed integral with the stent.
6. The device of claim 1 wherein one of the first or second elements is formed at least in part of copper.
7. The device of claim 1 wherein one of the first and second element is formed at least in part of iron.
8. The device of claim 1 wherein said first element is contained within said second element.
9. The device of claim 1 wherein at least one of the elements is helically shaped.
10. The device of claim 6 wherein both of the elements are helically shaped.
11. The device as in claim 10 wherein one helically shaped element is contained within another helically shaped element.
12. The device of claim 10 wherein one helically shaped element is disposed within coils of another helically shaped element along at least a part of the length of the device.
13. The device of claim 1 wherein the occluding component is provided with fibrous member having a plurality of strands secured thereto.
14. The device of claim 13 wherein one of the strands of the fibrous member is the first metallic element.
15. The device of claim 14 wherein one of the strands of the fibrous member is the second metallic element.
16. The device of claim 13 wherein the fibrous member has a plurality of strands in a mesh construction.
17. The device of claim 13 wherein the fibrous member is disposed within an inner lumen of the occluding component.
18. The device of claim 13 wherein the fibrous material is disposed on the occluding component.
19. The device of claim 1 wherein the first metallic element is a granule.
20. The device of claim 1 wherein both the first and second metallic elements are granules.
21. The device of claim 1 wherein the occluding component is a tubular member and the first and second elements are granules disposed on an exterior surface of the tubular member.
22. The device of claim 1 wherein the first element is a planar member, the second element is a planar member and the first and second elements are coplanar along at least a portion of each other.
23. The device of claim 22 wherein said first and second elements are secured together along at least part of the co-planar portions thereof.
24. The device of claim 1 wherein the occluding component has an elongated shaft and a plurality of expandable spider like elements are provided along the elongated shaft.
25. The device of claim 24 wherein one section of the occluding component having one spider-like element is formed at least in part of a first metallic material and a second section of the occluding component is formed of a second metallic material different from the first metallic material.
26. The device of claim 24 wherein the occluding component is formed of a first metallic material and an element formed of a second metallic material different from the first metallic material is secured to the occluding component.
27. The device of claim 26 wherein the element formed of a second metallic material is in the form of a collar or sleeve secured to the occluding component.
28. The device of claim 1 wherein the first and second metallic elements are configured to be electrically connected to an electrical power source.
29. The device of claim 28 wherein the electrical power source is a battery.
30. The device of claim 28 wherein the first and second metallic elements are in the form of first and second helical coils respectively.
31. The device of claim 30 wherein the first helical coil has space between adjacent turns of the helical coil.
32. The device of claim 31 wherein the second helical coil is fitted within the space between the turns of the first helical coil.
33. An expandable device for occluding a patient's body lumen, comprising: a. an expandable occluding component; b. a first element which is associated with the occlusion component and which is formed at least in part of a first metallic material; and c. a second element which is associated with the occlusion component, which is formed at least in part of a second metallic material different from the first metallic material; and d. an electrical connection between the first and second metallic elements configured to generate sufficient electrical activity between the first and second metallic elements to stimulate tissue growth within the body lumen when in contact with conductive fluid within the body lumen.
34. An expandable device for occluding a patient's body lumen, comprising: a. an expandable occluding means; b. a first means which is formed of a first metallic material and is associated with the occluding means for generating electrical activity with a second means which is formed at least in part of a second metallic material and which is associated with the occlusion component; and c. an electrical connection means between the first and second metallic means for generating sufficient electrical activity between the first and second metallic elements to stimulate tissue growth within the body lumen when in contact with conductive fluid within the body lumen.
35. A system for sterilizing a patient, comprising: a. means for an occluding device having an expandable occluding component, a first metallic element which is at least in part formed of metallic material and second metallic element which is at least in part formed of a metallic material and which is electrically connected to the first metallic element; b. means for introducing the occluding device into a reproductive lumen of the patient; c. means for expanding the occluding component of the occluding device within the patient's reproductive lumen; d. means for maintaining the first and second metallic elements within the reproductive lumen in contact with an electrolytic fluid; and d. means for causing an electrical activity between the first and second elements to enhance tissue growth within or onto the occluding component.
36. A contraceptive device for occluding a patient's reproductive lumen, comprising: a. an expandable occluding component; b. a first metallic element which is associated with the occluding component; and c. a second metallic element which is associated with the occluding component; d. an electrical power source; e. a first electrical conductor electrically connected between the first metallic element and the power source; and f. a second electrical conductor electrically connected between the second metallic element and the electrical power source.
PCT/US2005/003310 2004-02-02 2005-01-31 Enhancing tissue ingrowth for contraception WO2005074845A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2005800097909A CN1937976B (en) 2004-02-02 2005-01-31 Enhancing tissue ingrowth for contraception
EP05722687A EP1715826B1 (en) 2004-02-02 2005-01-31 Enhancing tissue ingrowth for contraception
CA2555011A CA2555011C (en) 2004-02-02 2005-01-31 Enhancing tissue ingrowth for contraception
AU2005209871A AU2005209871B2 (en) 2004-02-02 2005-01-31 Enhancing tissue ingrowth for contraception

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54182104P 2004-02-02 2004-02-02
US60/541,821 2004-02-02

Publications (1)

Publication Number Publication Date
WO2005074845A1 true WO2005074845A1 (en) 2005-08-18

Family

ID=34837521

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/003310 WO2005074845A1 (en) 2004-02-02 2005-01-31 Enhancing tissue ingrowth for contraception

Country Status (6)

Country Link
US (2) US20060009798A1 (en)
EP (1) EP1715826B1 (en)
CN (3) CN1937976B (en)
AU (1) AU2005209871B2 (en)
CA (1) CA2555011C (en)
WO (1) WO2005074845A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2337506A1 (en) * 2008-08-06 2011-06-29 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
EP2340077A1 (en) * 2008-09-11 2011-07-06 AGA Medical Corporation Device for occluding vascular defects
EP1715826B1 (en) * 2004-02-02 2013-03-06 Conceptus, Inc. Enhancing tissue ingrowth for contraception
EP2768424A1 (en) * 2011-10-18 2014-08-27 Anaxiom Corporation Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery
US9445798B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US9877710B2 (en) 2004-03-19 2018-01-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
WO2019178579A1 (en) * 2018-03-16 2019-09-19 Boston Scientific Scimed, Inc. Devices for vein closure
WO2021013352A1 (en) * 2019-07-25 2021-01-28 Clearstream Technologies Limited Embolisation device for promoting blood clot formation and a method of retrieving the same from a bodily lumen

Families Citing this family (172)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845711B2 (en) * 2007-10-19 2014-09-30 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US6471635B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
AU759363B2 (en) 2000-02-10 2003-04-10 Implantica Patent Ltd. Controlled urinary incontinence treatment
DE60128971T2 (en) 2000-02-10 2008-02-07 Potencia Medical Ag Mechanical device for impotence treatment
CN1400888A (en) 2000-02-11 2003-03-05 波滕西亚医疗公司 Impotence treatment apparatus with energy transforming means
ATE324087T1 (en) 2000-02-14 2006-05-15 Potencia Medical Ag MALE IMPOTENCY PROSTHESIS DEVICE WITH WIRELESS POWER SUPPLY
AU2001232586A1 (en) 2000-02-14 2001-07-09 Potencia Medical Ag Penile prosthesis
ES2399091T3 (en) 2001-12-05 2013-03-25 Keystone Heart Ltd. Endovascular device for entrapment of particulate matter and method of use
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
US7335213B1 (en) 2002-11-15 2008-02-26 Abbott Cardiovascular Systems Inc. Apparatus and methods for heart valve repair
US9149602B2 (en) 2005-04-22 2015-10-06 Advanced Cardiovascular Systems, Inc. Dual needle delivery system
US8187324B2 (en) * 2002-11-15 2012-05-29 Advanced Cardiovascular Systems, Inc. Telescoping apparatus for delivering and adjusting a medical device in a vessel
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US7404824B1 (en) 2002-11-15 2008-07-29 Advanced Cardiovascular Systems, Inc. Valve aptation assist device
US7981152B1 (en) 2004-12-10 2011-07-19 Advanced Cardiovascular Systems, Inc. Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites
US7998112B2 (en) 2003-09-30 2011-08-16 Abbott Cardiovascular Systems Inc. Deflectable catheter assembly and method of making same
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
US8747453B2 (en) * 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8313505B2 (en) * 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
US8517027B2 (en) * 2004-09-03 2013-08-27 Boston Scientific Scimed, Inc. Reversible vessel seal
US8795315B2 (en) * 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
TW200635566A (en) * 2005-01-25 2006-10-16 Vnus Med Tech Inc Structures for permanent occlusion of a hollow anatomical structure
US8221446B2 (en) 2005-03-15 2012-07-17 Cook Medical Technologies Embolic protection device
US8945169B2 (en) 2005-03-15 2015-02-03 Cook Medical Technologies Llc Embolic protection device
US20060259132A1 (en) * 2005-05-02 2006-11-16 Cook Incorporated Vascular stent for embolic protection
US8187298B2 (en) * 2005-08-04 2012-05-29 Cook Medical Technologies Llc Embolic protection device having inflatable frame
US8377092B2 (en) * 2005-09-16 2013-02-19 Cook Medical Technologies Llc Embolic protection device
US8632562B2 (en) * 2005-10-03 2014-01-21 Cook Medical Technologies Llc Embolic protection device
US20070078479A1 (en) * 2005-10-04 2007-04-05 Boston Scientific Scimed, Inc. Self-expanding vaso-occlusive devices with regulated expansion
US8182508B2 (en) * 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US8252017B2 (en) * 2005-10-18 2012-08-28 Cook Medical Technologies Llc Invertible filter for embolic protection
US8216269B2 (en) * 2005-11-02 2012-07-10 Cook Medical Technologies Llc Embolic protection device having reduced profile
US8152831B2 (en) * 2005-11-17 2012-04-10 Cook Medical Technologies Llc Foam embolic protection device
US20070208213A1 (en) * 2006-02-03 2007-09-06 Swann Susan E Method and apparatus for in-vitro fertilization and tubal occlusion
US9017361B2 (en) * 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US8062324B2 (en) * 2006-05-08 2011-11-22 S.M.T. Research And Development Ltd. Device and method for vascular filter
US7975697B2 (en) 2006-05-11 2011-07-12 Conceptus, Inc. Methods and apparatus for occluding reproductive tracts to effect contraception
US20080071307A1 (en) 2006-09-19 2008-03-20 Cook Incorporated Apparatus and methods for in situ embolic protection
US20080097469A1 (en) * 2006-10-18 2008-04-24 Gruber William H Intrauterine access and procedure system with laterally deflectable sheath
US20080146872A1 (en) * 2006-11-07 2008-06-19 Gruber William H Mechanical distension systems for performing a medical procedure in a remote space
US8025656B2 (en) * 2006-11-07 2011-09-27 Hologic, Inc. Methods, systems and devices for performing gynecological procedures
US8784439B1 (en) * 2006-11-28 2014-07-22 Stephen V. Ward Percutaneous medical procedures and devices for closing vessels using mechanical closures
US9901434B2 (en) 2007-02-27 2018-02-27 Cook Medical Technologies Llc Embolic protection device including a Z-stent waist band
EP2134283B1 (en) * 2007-04-06 2014-06-11 Hologic, Inc. System and device for tissue removal
US20090270898A1 (en) 2007-04-06 2009-10-29 Interlace Medical, Inc. Tissue removal device with high reciprocation rate
US9259233B2 (en) 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
US9095366B2 (en) * 2007-04-06 2015-08-04 Hologic, Inc. Tissue cutter with differential hardness
US8983609B2 (en) * 2007-05-30 2015-03-17 The Cleveland Clinic Foundation Apparatus and method for treating pulmonary conditions
US8133268B2 (en) * 2007-05-30 2012-03-13 Cordis Corporation Stent/fiber structural combinations
US20110022149A1 (en) 2007-06-04 2011-01-27 Cox Brian J Methods and devices for treatment of vascular defects
US8328840B2 (en) 2007-07-09 2012-12-11 Artventive Medical Group, Inc. Methods and apparatus for rapid endovascular vessel occlusion and blood flow interruption
US20090030500A1 (en) * 2007-07-27 2009-01-29 Jan Weber Iron Ion Releasing Endoprostheses
US8100129B2 (en) * 2007-08-28 2012-01-24 Conceptus, Inc. Methods and devices for occluding an ovarian pathway
US8292907B2 (en) * 2007-08-31 2012-10-23 Cook Medical Technologies Llc Balloon assisted occlusion device
US20090062839A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Barbed stent vascular occlusion device
US8052745B2 (en) * 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8419748B2 (en) * 2007-09-14 2013-04-16 Cook Medical Technologies Llc Helical thrombus removal device
US9138307B2 (en) * 2007-09-14 2015-09-22 Cook Medical Technologies Llc Expandable device for treatment of a stricture in a body vessel
US8252018B2 (en) * 2007-09-14 2012-08-28 Cook Medical Technologies Llc Helical embolic protection device
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
EP3871623A1 (en) * 2007-10-11 2021-09-01 Implantica Patent Ltd Device and method for embryo control
US9949871B2 (en) * 2007-10-11 2018-04-24 Peter Forsell Method for controlling flow of eggs in a uterine tube
US8696543B2 (en) 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
US10195325B2 (en) * 2007-10-11 2019-02-05 Peter Forsell Method for controlling flow of sperms in a uterine tube
SI2211768T1 (en) 2007-10-11 2021-11-30 Implantica Patent Ltd. Apparatus for controlling flow in a bodily organ
US8992409B2 (en) 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
US20090099591A1 (en) 2007-10-15 2009-04-16 Boston Scientific Scimed, Inc. Coil Anchor Systems and Methods of Use
US8114116B2 (en) * 2008-01-18 2012-02-14 Cook Medical Technologies Llc Introduction catheter set for a self-expandable implant
EP4088772A1 (en) * 2008-01-28 2022-11-16 Implantica Patent Ltd. A drainage device
EP2240138B1 (en) 2008-01-29 2021-07-21 Implantica Patent Ltd. Apparatus for treating obesity
US20100256661A1 (en) * 2009-04-06 2010-10-07 Zeev Brandeis Apparatus and method for enabling perforating vein ablation
CA3048277C (en) * 2008-05-02 2022-06-21 Sequent Medical Inc. Filamentary devices for treatment of vascular defects
EP2404580B1 (en) 2008-05-16 2013-04-03 Conceptus, Inc. Occlusion device and system for occluding a reproductive body lumen
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US8322341B2 (en) * 2008-09-09 2012-12-04 Conceptus, Inc. System and method for occluding a reproductive body lumen
US11123171B2 (en) 2008-10-10 2021-09-21 Peter Forsell Fastening means for implantable medical control assembly
EP3909559A1 (en) 2008-10-10 2021-11-17 Medical Tree Patent Ltd Heart help device and system
EP2349025B1 (en) 2008-10-10 2015-09-16 Kirk Promotion LTD. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
WO2010042006A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. Heart help method
US10219898B2 (en) 2008-10-10 2019-03-05 Peter Forsell Artificial valve
US8600510B2 (en) 2008-10-10 2013-12-03 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
US9427304B2 (en) * 2008-10-27 2016-08-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer device with gap for treating a target site and associated method
US8356600B2 (en) * 2008-11-11 2013-01-22 Conceptus, Inc. Occlusion implant
EP2349023B1 (en) * 2008-11-26 2017-03-15 Cook Medical Technologies LLC Vascular occlusion device
US9320525B2 (en) * 2008-12-03 2016-04-26 Boston Scientific Scimed, Inc. Occlusion stent
AU2009327376B2 (en) * 2008-12-19 2013-08-22 Covidien Lp Method and apparatus for storage and/or introduction of implant for hollow anatomical structure
US8388644B2 (en) 2008-12-29 2013-03-05 Cook Medical Technologies Llc Embolic protection device and method of use
WO2010081039A1 (en) 2009-01-08 2010-07-15 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20100211094A1 (en) * 2009-02-18 2010-08-19 Cook Incorporated Umbrella distal embolic protection device
US8241298B2 (en) 2009-03-27 2012-08-14 Depuy Mitek, Inc. Methods and devices for delivering and affixing tissue scaffolds
US8308814B2 (en) 2009-03-27 2012-11-13 Depuy Mitek, Inc. Methods and devices for preparing and implanting tissue scaffolds
US20100274277A1 (en) * 2009-04-27 2010-10-28 Cook Incorporated Embolic protection device with maximized flow-through
US8701670B2 (en) * 2009-04-29 2014-04-22 Bayer Essure Inc. Trackable occlusion device and catheter system
US11903602B2 (en) 2009-04-29 2024-02-20 Hologic, Inc. Uterine fibroid tissue removal device
US9351716B2 (en) 2009-06-17 2016-05-31 Coherex Medical, Inc. Medical device and delivery system for modification of left atrial appendage and methods thereof
US10064628B2 (en) 2009-06-17 2018-09-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9649115B2 (en) 2009-06-17 2017-05-16 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10631969B2 (en) 2009-06-17 2020-04-28 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9693780B2 (en) 2009-06-17 2017-07-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US20110061659A1 (en) * 2009-09-17 2011-03-17 Julian Cruzada Minimally invasive delivery devices and methods
WO2011049795A1 (en) * 2009-10-19 2011-04-28 Wilson-Cook Medical Inc. Balloon-tipped endoscopic system with inverted sleeve
US20110152993A1 (en) * 2009-11-05 2011-06-23 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US9457171B2 (en) 2009-12-02 2016-10-04 Renovorx, Inc. Devices, methods and kits for delivery of therapeutic materials to a target artery
US10512761B2 (en) 2009-12-02 2019-12-24 Renovorx, Inc. Methods for delivery of therapeutic materials to treat pancreatic cancer
WO2012002944A1 (en) 2010-06-29 2012-01-05 Artventive Medical Group, Inc. Reducing flow through a tubular structure
WO2012027500A2 (en) 2010-08-24 2012-03-01 Edwards Lifesciences Corporation Flexible annuloplasty ring with select control points
JP2012090949A (en) * 2010-09-27 2012-05-17 Terumo Corp Guide wire for endoscope
WO2012050836A1 (en) * 2010-09-28 2012-04-19 Cook Biotech Incorporated Devices and methods for treating fistulae and other bodily openings and passageways
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9463036B2 (en) 2010-10-22 2016-10-11 Neuravi Limited Clot engagement and removal system
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
WO2012120490A2 (en) 2011-03-09 2012-09-13 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
CA2835427A1 (en) * 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
WO2012161953A2 (en) 2011-05-23 2012-11-29 Stryker Corporation Vaso-occlusive devices with in-situ stiffening
US20120330342A1 (en) * 2011-06-27 2012-12-27 Jones Donald K Systems and devices for intralumenal implantation
EP2755574A1 (en) * 2011-09-13 2014-07-23 Stryker Corporation Vaso-occlusive device
EP3682813B1 (en) 2011-11-01 2023-12-27 Coherex Medical, Inc. Medical device for modification of left atrial appendage
US9011481B2 (en) 2012-12-30 2015-04-21 Cook Medical Technologies Llc Vascular occlusion device having a jelly fish
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
SI2967610T1 (en) * 2013-03-14 2019-07-31 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
TR201901830T4 (en) 2013-03-14 2019-03-21 Neuravi Ltd Devices and methods for the removal of acute blockages from blood vessels.
WO2014197362A1 (en) * 2013-06-03 2014-12-11 Ramtin Agah Devices, methods and kits for delivery of therapeutic materials to a pancreas
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9795400B2 (en) 2013-11-13 2017-10-24 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
WO2016039979A2 (en) * 2014-09-08 2016-03-17 Stryker Corporation Vaso-occlusive devices with in-situ stiffening
WO2016086051A1 (en) * 2014-11-24 2016-06-02 Cirrus Technologies Kft Systems and methods for permanent female contraception
JP2017535352A (en) 2014-11-26 2017-11-30 ニューラヴィ・リミテッド Clot collection device for removing obstructive clots from blood vessels
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
US10265076B2 (en) * 2015-03-16 2019-04-23 Steven Clark Block Vascular occluding bridged self-expanding metal stent (VOBSEMS)
US10265515B2 (en) * 2015-03-27 2019-04-23 Covidien Lp Galvanically assisted aneurysm treatment
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
CN109688940B (en) * 2016-06-10 2020-09-22 泰尔茂株式会社 Blood vessel plugging device
MX2019002565A (en) 2016-09-06 2019-09-18 Neuravi Ltd A clot retrieval device for removing occlusive clot from a blood vessel.
US11052224B2 (en) 2017-05-18 2021-07-06 Renovorx, Inc. Methods for treating cancerous tumors
US10695543B2 (en) 2017-05-18 2020-06-30 Renovorx, Inc. Methods for treating cancerous tumors
US20220104840A1 (en) 2017-10-16 2022-04-07 Retriever Medical, Inc. Clot Removal Methods and Devices with Multiple Independently Controllable Elements
US20220104839A1 (en) 2017-10-16 2022-04-07 Retriever Medical, Inc. Clot Removal Methods and Devices with Multiple Independently Controllable Elements
US20190110804A1 (en) 2017-10-16 2019-04-18 Michael Bruce Horowitz Catheter based retrieval device with proximal body having axial freedom of movement
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
US11439401B2 (en) * 2018-11-16 2022-09-13 Microvention, Inc. Embolic coil
FI130702B1 (en) * 2018-12-18 2024-01-26 Miikka Frant A device applicable to insertion into a vein of a human patient
WO2020190620A1 (en) 2019-03-15 2020-09-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
CN113573765A (en) 2019-03-15 2021-10-29 后续医疗股份有限公司 Silk device for treating vascular defects
US11369355B2 (en) 2019-06-17 2022-06-28 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11937836B2 (en) 2020-06-22 2024-03-26 Neuravi Limited Clot retrieval system with expandable clot engaging framework
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US11812969B2 (en) 2020-12-03 2023-11-14 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11937837B2 (en) 2020-12-29 2024-03-26 Neuravi Limited Fibrin rich / soft clot mechanical thrombectomy device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009158A1 (en) * 1989-02-07 1990-08-23 Radelkis Elektrokémiai Mu^'szergyártó Ipari Szövetkezet Intrauterine contraceptive device
US5433217A (en) * 1988-09-14 1995-07-18 Pianetti; Francesco Bimetallic spiral intrauterine device
US20020020417A1 (en) 1995-06-07 2002-02-21 Nikolchev Julian N. Contraceptive transcervical fallopian tube occlusion devices and methods
US20020029051A1 (en) * 1996-12-18 2002-03-07 Edward J. Lynch Occluding device and method of use
EP1199049A1 (en) * 1998-08-10 2002-04-24 Itzhak Dr. Shoher Metallic composite surface composition for an implant structure

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US452764A (en) * 1891-05-19 Frederick salathe
US3334629A (en) * 1964-11-09 1967-08-08 Bertram D Cohn Occlusive device for inferior vena cava
US3655996A (en) * 1969-03-13 1972-04-11 Iwatsu Electric Co Ltd Protective circuit for input circuit of junction type field effect transistor
US3834394A (en) * 1969-11-21 1974-09-10 R Sessions Occlusion device and method and apparatus for inserting the same
US3687129A (en) * 1970-10-02 1972-08-29 Abcor Inc Contraceptive device and method of employing same
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3815678A (en) * 1971-09-07 1974-06-11 Allied Chem Hydrocarbon sweep process
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3815578A (en) * 1973-05-11 1974-06-11 Investors In Ventures Inc Method of inserting an implant into a portion of a tubular organ whose mucous lining has been partially removed
US3995108A (en) * 1975-05-21 1976-11-30 Ampex Corporation Television aperture correction system having gateable coring means for noise cancellation
US4052754A (en) * 1975-08-14 1977-10-11 Homsy Charles A Implantable structure
US3991760A (en) * 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
US4185618A (en) * 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4186618A (en) * 1977-08-05 1980-02-05 Eaton Corporation Transmission input decelerating and reversing mechanism
US4246896A (en) * 1978-10-30 1981-01-27 Dynatech Corp. Intracervical cuff (ICC) for contraception and prevention of venereal disease and applicator therefor
US4248896A (en) * 1979-03-01 1981-02-03 Wallace Leland C Process for baking bread
US4279252A (en) * 1979-08-24 1981-07-21 Martin Michael T X-ray scaling catheter
JPS5845379B2 (en) * 1979-11-09 1983-10-08 アイシン精機株式会社 Automotive brake booster
US4311146A (en) * 1980-05-08 1982-01-19 Sorenson Research Co., Inc. Detachable balloon catheter apparatus and method
US4657000A (en) * 1981-07-23 1987-04-14 Dynasplints Systems, Inc. Adjustable splint and securing means therefor
FR2522959A1 (en) * 1982-03-15 1983-09-16 Hamou Jacques Tubular pessary for reversible pregnancy protection - has soft central tubular section with proximal and distal loop of fibrous material
US4441495A (en) * 1982-08-16 1984-04-10 Becton, Dickinson And Company Detachable balloon catheter device and method of use
US4638803A (en) * 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US5190546A (en) * 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US4787899A (en) * 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4606336A (en) * 1984-11-23 1986-08-19 Zeluff James W Method and apparatus for non-surgically sterilizing female reproductive organs
FR2573646B1 (en) * 1984-11-29 1988-11-25 Celsa Composants Electr Sa PERFECTED FILTER, PARTICULARLY FOR THE RETENTION OF BLOOD CLOTS
US4705517A (en) * 1985-09-03 1987-11-10 Becton, Dickinson And Company Percutaneously deliverable intravascular occlusion prosthesis
US4700701A (en) * 1985-10-23 1987-10-20 Montaldi David H Sterilization method and apparatus
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4964850A (en) * 1986-05-07 1990-10-23 Vincent Bouton Method for treating trans-nasal sinus afflictions using a double t-shaped trans-nasal aerator
US4869268A (en) * 1987-05-14 1989-09-26 Inbae Yoon Multi-functional instruments and stretchable ligating and occluding devices
US4969458A (en) * 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US4787699A (en) * 1987-09-01 1988-11-29 Hughes Aircraft Company Fiber optic terminus
US4904069A (en) * 1987-12-14 1990-02-27 Ichikoh Industries, Ltd. Fresnel-type aspheric prism lens
US4857000A (en) * 1988-02-16 1989-08-15 Tektronix, Inc. Circuit board ejector/guide
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
FR2641692A1 (en) * 1989-01-17 1990-07-20 Nippon Zeon Co Plug for closing an opening for a medical application, and device for the closure plug making use thereof
CH678393A5 (en) * 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
US5163958A (en) * 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US5116318A (en) * 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US5919202A (en) * 1989-12-05 1999-07-06 Yoon; Inbae Surgical instrument with jaws and movable internal needle and method for use thereof
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5197878A (en) * 1990-10-23 1993-03-30 Thomas A. Lukase Clamp for removing a dental prosthetic
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
CA2202800A1 (en) * 1991-04-11 1992-10-12 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
US5267945A (en) * 1991-04-24 1993-12-07 David Doctor Finger splint for treating pip joint injuries
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5147370A (en) * 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5474089A (en) * 1991-06-26 1995-12-12 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method and device for reversible sterilization
US5458713A (en) * 1991-09-25 1995-10-17 Gao Gesellschaft Fuer Automation Und Organisation Mbh Multilayer data carrier and a method for producing it
US5226911A (en) * 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5456713A (en) * 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
US5167614A (en) * 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent
US5176692A (en) * 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5626605A (en) * 1991-12-30 1997-05-06 Scimed Life Systems, Inc. Thrombosis filter
US5176240A (en) * 1992-03-05 1993-01-05 Overton Corporation Indexing machine with roller cam drive
US5303719A (en) * 1992-08-14 1994-04-19 Wilk Peter J Surgical method and associated instrument assembly
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5423849A (en) * 1993-01-15 1995-06-13 Target Therapeutics, Inc. Vasoocclusion device containing radiopaque fibers
US5512051A (en) * 1993-02-16 1996-04-30 Boston Scientific Corporation Slip-layered catheter balloon
WO1995010862A1 (en) * 1993-10-14 1995-04-20 Deltec New Zealand Limited A variable differential phase shifter
US5487377A (en) * 1993-11-05 1996-01-30 Clinical Innovation Associates, Inc. Uterine manipulator and manipulator tip assembly
JP3185906B2 (en) * 1993-11-26 2001-07-11 ニプロ株式会社 Prosthesis for atrial septal defect
US5490996A (en) * 1994-01-11 1996-02-13 Kraft Jacobs Suchard Ag Process for producing an improved sucrose-free milk chocolate
US5405000A (en) * 1994-02-28 1995-04-11 Hagedon; Bryan D. Protective suspension package
US5499995C1 (en) * 1994-05-25 2002-03-12 Paul S Teirstein Body passageway closure apparatus and method of use
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5507611A (en) * 1995-01-24 1996-04-16 Collister; Frank C. Key bolt fastener
US5634936A (en) * 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
DE19508805C2 (en) * 1995-03-06 2000-03-30 Lutz Freitag Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions
US6143007A (en) * 1995-04-28 2000-11-07 Target Therapeutics, Inc. Method for making an occlusive device
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US5766203A (en) * 1995-07-20 1998-06-16 Intelliwire, Inc. Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method
CN1141158A (en) * 1995-07-25 1997-01-29 温学强 Contraceptive suppository spaced in oviduct
US5601600A (en) * 1995-09-08 1997-02-11 Conceptus, Inc. Endoluminal coil delivery system having a mechanical release mechanism
US6090063A (en) * 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
US6090083A (en) * 1996-01-31 2000-07-18 Scimed Life Systems, Inc. Low profile valve and balloon catheter
JP2000504594A (en) * 1996-02-02 2000-04-18 トランスバスキュラー インコーポレイテッド Method and apparatus for blocking flow in a blood vessel
US6270495B1 (en) * 1996-02-22 2001-08-07 Radiotherapeutics Corporation Method and device for enhancing vessel occlusion
US5669933A (en) * 1996-07-17 1997-09-23 Nitinol Medical Technologies, Inc. Removable embolus blood clot filter
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US6042590A (en) * 1997-06-16 2000-03-28 Novomedics, Llc Apparatus and methods for fallopian tube occlusion
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US7491232B2 (en) * 1998-09-18 2009-02-17 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods with implantation force resolution
US6145506A (en) * 1998-04-14 2000-11-14 Goll; Dawn M. Decorative penile wrap
US6093194A (en) * 1998-09-14 2000-07-25 Endocare, Inc. Insertion device for stents and methods for use
US6112747A (en) * 1998-11-06 2000-09-05 Jones; Jesse M. Method of sterilizing females
DE19857103A1 (en) * 1998-12-10 2000-06-15 Bsh Bosch Siemens Hausgeraete Household dishwasher
US6231589B1 (en) * 1999-03-22 2001-05-15 Microvena Corporation Body vessel filter
US6034361A (en) * 1999-04-28 2000-03-07 Hewlett-Packard Company System for monitoring the progress of a chemical reaction in a microwave-assisted heating system
US6267776B1 (en) * 1999-05-03 2001-07-31 O'connell Paul T. Vena cava filter and method for treating pulmonary embolism
WO2001011739A1 (en) * 1999-08-10 2001-02-15 Coretek, Inc. Single etalon optical wavelength reference device
US6709667B1 (en) * 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
ATE492251T1 (en) * 1999-08-23 2011-01-15 Conceptus Inc TUBAL CONTRACEPTIVE DELIVERY AND DEPLOYMENT CATHETER SYSTEM
KR100337308B1 (en) * 2000-08-21 2002-05-17 이계안 Bushing in suspension arm of vehicle
US6716238B2 (en) * 2001-05-10 2004-04-06 Scimed Life Systems, Inc. Stent with detachable tethers and method of using same
US20030066533A1 (en) * 2001-10-05 2003-04-10 Loy Randall A. Removable fallopian tube plug and associated methods
US6643311B2 (en) * 2001-10-23 2003-11-04 William F. Krupke Diode-pumped alkali laser
US7431729B2 (en) * 2002-06-05 2008-10-07 Nmt Medical, Inc. Patent foramen ovale (PFO) closure device with radial and circumferential support
WO2004041021A2 (en) * 2002-10-31 2004-05-21 Conair Corporation Hair treatment system and method
US7321682B2 (en) * 2002-11-12 2008-01-22 Namco Bandai Games, Inc. Image generation system, image generation method, program, and information storage medium
US20040169324A1 (en) * 2003-02-28 2004-09-02 Bottene Marlon V. Strut spring seat
US20040211428A1 (en) * 2003-02-28 2004-10-28 Sunrise Medical Hhg Inc. Nasal mask cushion
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
CN1937976B (en) * 2004-02-02 2011-12-07 孕体有限公司 Enhancing tissue ingrowth for contraception

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433217A (en) * 1988-09-14 1995-07-18 Pianetti; Francesco Bimetallic spiral intrauterine device
WO1990009158A1 (en) * 1989-02-07 1990-08-23 Radelkis Elektrokémiai Mu^'szergyártó Ipari Szövetkezet Intrauterine contraceptive device
US20020020417A1 (en) 1995-06-07 2002-02-21 Nikolchev Julian N. Contraceptive transcervical fallopian tube occlusion devices and methods
US20020029051A1 (en) * 1996-12-18 2002-03-07 Edward J. Lynch Occluding device and method of use
US6432116B1 (en) 1996-12-18 2002-08-13 Ovion, Inc. Occluding device and method of use
EP1199049A1 (en) * 1998-08-10 2002-04-24 Itzhak Dr. Shoher Metallic composite surface composition for an implant structure

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715826B1 (en) * 2004-02-02 2013-03-06 Conceptus, Inc. Enhancing tissue ingrowth for contraception
US10624619B2 (en) 2004-03-19 2020-04-21 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US9445799B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US11134933B2 (en) 2004-03-19 2021-10-05 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US9877710B2 (en) 2004-03-19 2018-01-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US9039724B2 (en) 2004-03-19 2015-05-26 Aga Medical Corporation Device for occluding vascular defects
US9445798B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
EP2337506A1 (en) * 2008-08-06 2011-06-29 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
EP2340077A4 (en) * 2008-09-11 2015-03-11 Aga Medical Corp Device for occluding vascular defects
EP2340077A1 (en) * 2008-09-11 2011-07-06 AGA Medical Corporation Device for occluding vascular defects
EP2768424A1 (en) * 2011-10-18 2014-08-27 Anaxiom Corporation Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery
EP2768424A4 (en) * 2011-10-18 2014-12-24 Anaxiom Corp Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery
US10751060B2 (en) 2011-10-18 2020-08-25 Anaxiom Corporation Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery
US9861369B2 (en) 2011-10-18 2018-01-09 Anaxiom Corporation Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery
WO2019178579A1 (en) * 2018-03-16 2019-09-19 Boston Scientific Scimed, Inc. Devices for vein closure
US11109867B2 (en) 2018-03-16 2021-09-07 Boston Scientific Scimed, Inc. Devices and methods for vein closure
WO2021013352A1 (en) * 2019-07-25 2021-01-28 Clearstream Technologies Limited Embolisation device for promoting blood clot formation and a method of retrieving the same from a bodily lumen
US11504132B2 (en) 2019-07-25 2022-11-22 Clearstream Technologies Limited Embolisation device for promoting blood clot formation and a method of retrieving the same from a bodily lumen

Also Published As

Publication number Publication date
EP1715826A1 (en) 2006-11-02
CA2555011C (en) 2013-03-26
AU2005209871B2 (en) 2010-06-17
CN101627938B (en) 2011-12-21
CA2555011A1 (en) 2005-08-18
CN1929798A (en) 2007-03-14
CN1937976B (en) 2011-12-07
CN1937976A (en) 2007-03-28
US20050209633A1 (en) 2005-09-22
CN101627938A (en) 2010-01-20
US20060009798A1 (en) 2006-01-12
AU2005209871A1 (en) 2005-08-18
EP1715826B1 (en) 2013-03-06
CN100518693C (en) 2009-07-29

Similar Documents

Publication Publication Date Title
CA2555011C (en) Enhancing tissue ingrowth for contraception
US6096052A (en) Occluding device and method of use
US6432116B1 (en) Occluding device and method of use
AU2008243176B2 (en) Aneurysm treatment device
US20050217680A1 (en) Occluding device and method of use
US8100129B2 (en) Methods and devices for occluding an ovarian pathway
AU2008229892B2 (en) Occluding device and method of use
US20140213971A1 (en) Nerve impingement systems including an intravascular prosthesis and an extravascular prosthesis and associated systems and methods
EP1788991A1 (en) Reversible vessel seal
US9320525B2 (en) Occlusion stent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2555011

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005209871

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005722687

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005209871

Country of ref document: AU

Date of ref document: 20050131

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005209871

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 200580009790.9

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2005722687

Country of ref document: EP